Sibling validation of polygenic risk scores and complex trait prediction

23Citations
Citations of this article
86Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We test 26 polygenic predictors using tens of thousands of genetic siblings from the UK Biobank (UKB), for whom we have SNP genotypes, health status, and phenotype information in late adulthood. Siblings have typically experienced similar environments during childhood, and exhibit negligible population stratification relative to each other. Therefore, the ability to predict differences in disease risk or complex trait values between siblings is a strong test of genomic prediction in humans. We compare validation results obtained using non-sibling subjects to those obtained among siblings and find that typically most of the predictive power persists in between-sibling designs. In the case of disease risk we test the extent to which higher polygenic risk score (PRS) identifies the affected sibling, and also compute Relative Risk Reduction as a function of risk score threshold. For quantitative traits we examine between-sibling differences in trait values as a function of predicted differences, and compare to performance in non-sibling pairs. Example results: Given 1 sibling with normal-range PRS score (< 84 percentile, < + 1 SD) and 1 sibling with high PRS score (top few percentiles, i.e. > + 2 SD), the predictors identify the affected sibling about 70–90% of the time across a variety of disease conditions, including Breast Cancer, Heart Attack, Diabetes, etc. 55–65% of the time the higher PRS sibling is the case. For quantitative traits such as height, the predictor correctly identifies the taller sibling roughly 80 percent of the time when the (male) height difference is 2 inches or more.

References Powered by Scopus

GCTA: A tool for genome-wide complex trait analysis

5201Citations
N/AReaders
Get full text

The UK Biobank resource with deep phenotyping and genomic data

4593Citations
N/AReaders
Get full text

Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations

1943Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Utility of polygenic embryo screening for disease depends on the selection strategy

35Citations
N/AReaders
Get full text

Embryo screening for polygenic disease risk: Recent advances and ethical considerations

18Citations
N/AReaders
Get full text

Polygenic risk, population structure and ongoing difficulties with race in human genetics

13Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Lello, L., Raben, T. G., & Hsu, S. D. H. (2020). Sibling validation of polygenic risk scores and complex trait prediction. Scientific Reports, 10(1). https://doi.org/10.1038/s41598-020-69927-7

Readers over time

‘20‘21‘22‘23‘24‘25010203040

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 26

63%

Researcher 12

29%

Lecturer / Post doc 2

5%

Professor / Associate Prof. 1

2%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 18

47%

Medicine and Dentistry 10

26%

Agricultural and Biological Sciences 6

16%

Psychology 4

11%

Article Metrics

Tooltip
Mentions
Blog Mentions: 4
News Mentions: 1

Save time finding and organizing research with Mendeley

Sign up for free
0